Ventricular Assist Device Market: Global Industry Analysis and Forecast (2022-2029) – by Product, by Flow, by Design, by Application and by Region

Ventricular Assist Device Market was valued at US$ 2.55 Bn in 2021 and is expected to reach US$ 5.56 Bn by 2029, at a CAGR of 10.24% during the forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region. Ventricular Assist Device Market To know about the Research Methodology :- Request Free Sample Report

Ventricular Assist Device Market Dynamics:

Ventricular assist devices are pumps, which are used to support cardiac circulation in patients who have weakened hearts. Growing occurrences of heart failure across the globe, innovative technological advancements in ventricular assist devices, increasing awareness among patients about monitoring of the heart, and lack of heart donors are some of the prominent factors behind the growth of the global ventricular assist device market. Growing government funding for new product development coupled with ongoing research activities is expected to propel the growth of ventricular assist devices. New advancements in designs are also expected to boost the growth in demand. Innovative technologies contain the usage of centrifugal pumps, which precludes the blood from becoming static and escapes the risk of clotting. The high cost of ventricular assist devices and the implantation procedures are limiting the growth in the global ventricular assist device market. The ventricular assist devices are available in the market on average costs around and the total procedure costs around. The cost of the device and procedures is excessive to the low and middle-income patient population, which is declining the demand for ventricular assist devices.

Ventricular Assist Device Market Segment Analysis:

The left ventricular assist devices are expected to lead the global ventricular assist device market. The leading position in the market can be attributed to the growing number of patients who are suffering from last-stage heart failure, development in technology like effectiveness, high survival rate, and reduced risk of the devices. A growing number of patients suffering from cardiac complications like cardiomyopathy, stroke, and class III & class IV heart failure are likely to need a heart transplant. The destination therapy segment is projected to witness significant growth in the global ventricular assist device market. This therapy is one of the most preferred therapies, which is used in heart failure patients and creates a major and growing portion of the heart implants. The increasing usage of destination therapy for ventricular assist devices in patients suffering from end-stage heart failure is expected to propel the global ventricular assist device market growth.

Ventricular Assist Device Market Regional Insights:

Geographically, North America is estimated to hold a leading position in the global ventricular assist device market. The leading position in the market is attributed to the ongoing clinical trials for the testing of these devices and augmented government funding. Rising patient awareness about the availability of these ventricular assist devices and improved R&D activities for new product development is projected to boost the market growth. Furthermore, the Asia Pacific region is expected to grow at a xx % rate of CAGR during the forecast period. The region is projected to register productive growth during the forecast period (2022-2029) owing to the growing healthcare expenditure, and recent improvements in healthcare infrastructure in developing countries like China, Japan, and India. The development and up-gradation of devices are expected to increase the competition among key players. Some of the many key players are focusing on product endorsements and developing innovative products to reinforce their product portfolio, which strengthens the market competition. For instance, in 2021 FDA approved HeartMate 3 left ventricular assist device, which is developed by Abbott, as a destination therapy for patients with innovative heart failure. The objective of the report is to present a comprehensive assessment of the market and contain insights, facts, historical data, industry-validated market data, and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analyzing the market segments and, projects the global ventricular assist device market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global ventricular assist device market.

Ventricular Assist Device Market, Key Highlights:

• Global Ventricular Assist Device Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Ventricular Assist Device Market • Global Ventricular Assist Device Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Ventricular Assist Device Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Ventricular Assist Device Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Ventricular Assist Device Market are also profiled.

Ventricular Assist Device Market Scope Report: Inquire before buying

Global Ventricular Assist Device Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US$ 2.55 Bn.
Forecast Period 2022 to 2029 CAGR: 10.24% Market Size in 2029: US$ 5.56 Bn.
Segments Covered: by Product • Left Ventricular Assist Device • Right Ventricular Assist Device • Bi-Ventricular Assist Device
by Flow • Pulsatile Flow • Continuous Flow
by Design • Transcutaneous Ventricular Assist Devices • Implantable Ventricular Assist Devices
by Application • Bridge to Transplant • Destination Therapy • Bridge-to-recovery Therapy • Bridge-to-candidacy Therapy • Others

Ventricular Assist Device Market, by Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Ventricular Assist Device Market Key Players:

• CardiacAssist, Inc. • Berlin Heart GmbH • Jarvik Heart, Inc. • ABIOMED, Inc. • Medtronic plc. • Abbott Laboratories • ReliantHeart Inc. • Teleflex Incorporated • Carmat SA • Sun Medical Technology Research Corp. • Bivacor • Calon Cardio-Technology Ltd. • LivaNova PLC • Terumo Medical Corporation. • Evaheart Medical USA, Inc. • Fresenius Medical Care AG & Co. KGaA • Maquet GmbH • HeartWare International, Inc. • Thoratec • Cardiac Assist Frequently Asked Questions: 1. Which region has the largest share in Global Ventricular Assist Device Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Ventricular Assist Device Market? Ans: The Global Ventricular Assist Device Market is growing at a CAGR of 10.24% during forecasting period 2022-2029. 3. What is scope of the Global Ventricular Assist Device market report? Ans: Global Ventricular Assist Device Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Ventricular Assist Device market? Ans: The important key players in the Global Ventricular Assist Device Market are – CardiacAssist, Inc., Berlin Heart GmbH, Jarvik Heart, Inc., ABIOMED, Inc., Medtronic plc., Abbott Laboratories, ReliantHeart Inc., Teleflex Incorporated, Carmat SA, Sun Medical Technology Research Corp., Bivacor, Calon Cardio-Technology Ltd., LivaNova PLC, Terumo Medical Corporation., Evaheart Medical USA, Inc., Fresenius Medical Care AG & Co. KGaA, Maquet GmbH, HeartWare International, Inc., Thoratec, and Cardiac Assist 5. What is the study period of this market? Ans: The Global Ventricular Assist Device Market is studied from 2021 to 2029.

Global Ventricular Assist Device Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Ventricular Assist Device Market Size, by Market Value (US$ Bn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7.Global Ventricular Assist Device Market Industry Trends 4.8.Global Ventricular Assist Device Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Ventricular Assist Device Market Analysis and Forecast 6.1. Global Ventricular Assist Device Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Ventricular Assist Device Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Ventricular Assist Device Market Value Share Analysis, by Product 7.4. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Product 7.5. Global Ventricular Assist Device Market Analysis, by Product 7.6. Global Ventricular Assist Device Market Attractiveness Analysis, by Product 8. Global Ventricular Assist Device Market Analysis and Forecast, by Flow 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Ventricular Assist Device Market Value Share Analysis, by Flow 8.4. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Flow 8.5. Global Ventricular Assist Device Market Analysis, by Flow 8.6. Global Ventricular Assist Device Market Attractiveness Analysis, by Flow 9. Global Ventricular Assist Device Market Analysis and Forecast, by Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Ventricular Assist Device Market Value Share Analysis, by Application 9.4. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Application 9.5. Global Ventricular Assist Device Market Analysis, by Application 9.6. Global Ventricular Assist Device Market Attractiveness Analysis, by Application 10. Global Ventricular Assist Device Market Analysis and Forecast, by Design 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Ventricular Assist Device Market Value Share Analysis, by Design 10.4. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Design 10.5. Global Ventricular Assist Device Market Analysis, by Design 10.6. Global Ventricular Assist Device Market Attractiveness Analysis, by Design 11. Global Ventricular Assist Device Market Analysis, by Region 11.1. Global Ventricular Assist Device Market Value Share Analysis, by Region 11.2. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Region 11.3. Global Ventricular Assist Device Market Attractiveness Analysis, by Region 12. North America Ventricular Assist Device Market Analysis 12.1. Key Findings 12.2. North America Ventricular Assist Device Market Overview 12.3. North America Ventricular Assist Device Market Value Share Analysis, by Product 12.4. North America Ventricular Assist Device Market Forecast, by Product 12.4.1. Left Ventricular Assist Device 12.4.2. Right Ventricular Assist Device 12.4.3. Bi-Ventricular Assist Device 12.5. North America Ventricular Assist Device Market Value Share Analysis, by Flow 12.6. North America Ventricular Assist Device Market Forecast, by Flow 12.6.1. Pulsatile Flow 12.6.2. Continuous Flow 12.7. North America Ventricular Assist Device Market Value Share Analysis, by Application 12.8. North America Ventricular Assist Device Market Forecast, by Application 12.8.1. Bridge to Transplant 12.8.2. Destination Therapy 12.8.3. Bridge-to-recovery Therapy 12.8.4. Bridge-to-candidacy Therapy 12.8.5. Others 12.9. North America Ventricular Assist Device Market Value Share Analysis, by Design 12.10. North America Ventricular Assist Device Market Forecast, by Design 12.10.1. Transcutaneous Ventricular Assist Devices 12.10.2. Implantable Ventricular Assist Devices 12.11. North America Ventricular Assist Device Market Value Share Analysis, by Country 12.12. North America Ventricular Assist Device Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Ventricular Assist Device Market Analysis, by Country 12.14. U.S. Ventricular Assist Device Market Forecast, by Product 12.14.1. Left Ventricular Assist Device 12.14.2. Right Ventricular Assist Device 12.14.3. Bi-Ventricular Assist Device 12.15. U.S. Ventricular Assist Device Market Forecast, by Flow 12.15.1. Pulsatile Flow 12.15.2. Continuous Flow 12.16. U.S. Ventricular Assist Device Market Forecast, by Application 12.16.1. Bridge to Transplant 12.16.2. Destination Therapy 12.16.3. Bridge-to-recovery Therapy 12.16.4. Bridge-to-candidacy Therapy 12.16.5. Others 12.17. U.S. Ventricular Assist Device Market Forecast, by Design 12.17.1. Transcutaneous Ventricular Assist Devices 12.17.2. Implantable Ventricular Assist Devices 12.18. Canada Ventricular Assist Device Market Forecast, by Product 12.18.1. Left Ventricular Assist Device 12.18.2. Right Ventricular Assist Device 12.18.3. Bi-Ventricular Assist Device 12.19. Canada Ventricular Assist Device Market Forecast, by Flow 12.19.1. Pulsatile Flow 12.19.2. Continuous Flow 12.20. Canada Ventricular Assist Device Market Forecast, by Application 12.20.1. Bridge to Transplant 12.20.2. Destination Therapy 12.20.3. Bridge-to-recovery Therapy 12.20.4. Bridge-to-candidacy Therapy 12.20.5. Others 12.21. Canada Ventricular Assist Device Market Forecast, by Design 12.21.1. Transcutaneous Ventricular Assist Devices 12.21.2. Implantable Ventricular Assist Devices 12.22. North America Ventricular Assist Device Market Attractiveness Analysis 12.22.1. By Product 12.22.2. By Flow 12.22.3. By Application 12.22.4. By Design 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Ventricular Assist Device Market Analysis 13.1. Key Findings 13.2. Europe Ventricular Assist Device Market Overview 13.3. Europe Ventricular Assist Device Market Value Share Analysis, by Product 13.4. Europe Ventricular Assist Device Market Forecast, by Product 13.4.1. Left Ventricular Assist Device 13.4.2. Right Ventricular Assist Device 13.4.3. Bi-Ventricular Assist Device 13.5. Europe Ventricular Assist Device Market Value Share Analysis, by Flow 13.6. Europe Ventricular Assist Device Market Forecast, by Flow 13.6.1. Pulsatile Flow 13.6.2. Continuous Flow 13.7. Europe Ventricular Assist Device Market Value Share Analysis, by Application 13.8. Europe Ventricular Assist Device Market Forecast, by Application 13.8.1. Bridge to Transplant 13.8.2. Destination Therapy 13.8.3. Bridge-to-recovery Therapy 13.8.4. Bridge-to-candidacy Therapy 13.8.5. Others 13.9. Europe Ventricular Assist Device Market Value Share Analysis, by Design 13.10. Europe Ventricular Assist Device Market Forecast, by Design 13.10.1. Transcutaneous Ventricular Assist Devices 13.10.2. Implantable Ventricular Assist Devices 13.11. Europe Ventricular Assist Device Market Value Share Analysis, by Country 13.12. Europe Ventricular Assist Device Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Ventricular Assist Device Market Analysis, by Country 13.14. Germany Ventricular Assist Device Market Forecast, by Product 13.14.1. Left Ventricular Assist Device 13.14.2. Right Ventricular Assist Device 13.14.3. Bi-Ventricular Assist Device 13.15. Germany Ventricular Assist Device Market Forecast, by Flow 13.15.1. Pulsatile Flow 13.15.2. Continuous Flow 13.16. Germany Ventricular Assist Device Market Forecast, by Application 13.16.1. Bridge to Transplant 13.16.2. Destination Therapy 13.16.3. Bridge-to-recovery Therapy 13.16.4. Bridge-to-candidacy Therapy 13.16.5. Others 13.17. Germany Ventricular Assist Device Market Forecast, by Design 13.17.1. Transcutaneous Ventricular Assist Devices 13.17.2. Implantable Ventricular Assist Devices 13.18. U.K. Ventricular Assist Device Market Forecast, by Product 13.18.1. Left Ventricular Assist Device 13.18.2. Right Ventricular Assist Device 13.18.3. Bi-Ventricular Assist Device 13.19. U.K. Ventricular Assist Device Market Forecast, by Flow 13.19.1. Pulsatile Flow 13.19.2. Continuous Flow 13.20. U.K. Ventricular Assist Device Market Forecast, by Application 13.20.1. Bridge to Transplant 13.20.2. Destination Therapy 13.20.3. Bridge-to-recovery Therapy 13.20.4. Bridge-to-candidacy Therapy 13.20.5. Others 13.21. U.K. Ventricular Assist Device Market Forecast, by Design 13.21.1. Transcutaneous Ventricular Assist Devices 13.21.2. Implantable Ventricular Assist Devices 13.22. France Ventricular Assist Device Market Forecast, by Product 13.22.1. Left Ventricular Assist Device 13.22.2. Right Ventricular Assist Device 13.22.3. Bi-Ventricular Assist Device 13.23. France Ventricular Assist Device Market Forecast, by Flow 13.23.1. Pulsatile Flow 13.23.2. Continuous Flow 13.24. France Ventricular Assist Device Market Forecast, by Application 13.24.1. Bridge to Transplant 13.24.2. Destination Therapy 13.24.3. Bridge-to-recovery Therapy 13.24.4. Bridge-to-candidacy Therapy 13.24.5. Others 13.25. France Ventricular Assist Device Market Forecast, by Design 13.25.1. Transcutaneous Ventricular Assist Devices 13.25.2. Implantable Ventricular Assist Devices 13.26. Italy Ventricular Assist Device Market Forecast, by Product 13.26.1. Left Ventricular Assist Device 13.26.2. Right Ventricular Assist Device 13.26.3. Bi-Ventricular Assist Device 13.27. Italy Ventricular Assist Device Market Forecast, by Flow 13.27.1. Pulsatile Flow 13.27.2. Continuous Flow 13.28. Italy Ventricular Assist Device Market Forecast, by Application 13.28.1. Bridge to Transplant 13.28.2. Destination Therapy 13.28.3. Bridge-to-recovery Therapy 13.28.4. Bridge-to-candidacy Therapy 13.28.5. Others 13.29. Italy Ventricular Assist Device Market Forecast, by Design 13.29.1. Transcutaneous Ventricular Assist Devices 13.29.2. Implantable Ventricular Assist Devices 13.30. Spain Ventricular Assist Device Market Forecast, by Product 13.30.1. Left Ventricular Assist Device 13.30.2. Right Ventricular Assist Device 13.30.3. Bi-Ventricular Assist Device 13.31. Spain Ventricular Assist Device Market Forecast, by Flow 13.31.1. Pulsatile Flow 13.31.2. Continuous Flow 13.32. Spain Ventricular Assist Device Market Forecast, by Application 13.32.1. Bridge to Transplant 13.32.2. Destination Therapy 13.32.3. Bridge-to-recovery Therapy 13.32.4. Bridge-to-candidacy Therapy 13.32.5. Others 13.33. Spain Ventricular Assist Device Market Forecast, by Design 13.33.1. Transcutaneous Ventricular Assist Devices 13.33.2. Implantable Ventricular Assist Devices 13.34. Rest of Europe Ventricular Assist Device Market Forecast, by Product 13.34.1. Left Ventricular Assist Device 13.34.2. Right Ventricular Assist Device 13.34.3. Bi-Ventricular Assist Device 13.35. Rest of Europe Ventricular Assist Device Market Forecast, by Flow 13.35.1. Pulsatile Flow 13.35.2. Continuous Flow 13.36. Rest of Europe Ventricular Assist Device Market Forecast, by Application 13.36.1. Bridge to Transplant 13.36.2. Destination Therapy 13.36.3. Bridge-to-recovery Therapy 13.36.4. Bridge-to-candidacy Therapy 13.36.5. Others 13.37. Rest Of Europe Ventricular Assist Device Market Forecast, by Design 13.37.1. Transcutaneous Ventricular Assist Devices 13.37.2. Implantable Ventricular Assist Devices 13.38. Europe Ventricular Assist Device Market Attractiveness Analysis 13.38.1. By Product 13.38.2. By Flow 13.38.3. By Application 13.38.4. By Design 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Ventricular Assist Device Market Analysis 14.1. Key Findings 14.2. Asia Pacific Ventricular Assist Device Market Overview 14.3. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Product 14.4. Asia Pacific Ventricular Assist Device Market Forecast, by Product 14.4.1. Left Ventricular Assist Device 14.4.2. Right Ventricular Assist Device 14.4.3. Bi-Ventricular Assist Device 14.5. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Flow 14.6. Asia Pacific Ventricular Assist Device Market Forecast, by Flow 14.6.1. Pulsatile Flow 14.6.2. Continuous Flow 14.7. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Application 14.8. Asia Pacific Ventricular Assist Device Market Forecast, by Application 14.8.1. Bridge to Transplant 14.8.2. Destination Therapy 14.8.3. Bridge-to-recovery Therapy 14.8.4. Bridge-to-candidacy Therapy 14.8.5. Others 14.9. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Design 14.10. Asia Pacific Ventricular Assist Device Market Forecast, by Design 14.10.1. Transcutaneous Ventricular Assist Devices 14.10.2. Implantable Ventricular Assist Devices 14.11. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Country 14.12. Asia Pacific Ventricular Assist Device Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Ventricular Assist Device Market Analysis, by Country 14.14. China Ventricular Assist Device Market Forecast, by Product 14.14.1. Left Ventricular Assist Device 14.14.2. Right Ventricular Assist Device 14.14.3. Bi-Ventricular Assist Device 14.15. China Ventricular Assist Device Market Forecast, by Flow 14.15.1. Pulsatile Flow 14.15.2. Continuous Flow 14.16. China Ventricular Assist Device Market Forecast, by Application 14.16.1. Bridge to Transplant 14.16.2. Destination Therapy 14.16.3. Bridge-to-recovery Therapy 14.16.4. Bridge-to-candidacy Therapy 14.16.5. Others 14.17. China Ventricular Assist Device Market Forecast, by Design 14.17.1. Transcutaneous Ventricular Assist Devices 14.17.2. Implantable Ventricular Assist Devices 14.18. India Ventricular Assist Device Market Forecast, by Product 14.18.1. Left Ventricular Assist Device 14.18.2. Right Ventricular Assist Device 14.18.3. Bi-Ventricular Assist Device 14.19. India Ventricular Assist Device Market Forecast, by Flow 14.19.1. Pulsatile Flow 14.19.2. Continuous Flow 14.20. India Ventricular Assist Device Market Forecast, by Application 14.20.1. Bridge to Transplant 14.20.2. Destination Therapy 14.20.3. Bridge-to-recovery Therapy 14.20.4. Bridge-to-candidacy Therapy 14.20.5. 14.20.6. Others 14.21. India Ventricular Assist Device Market Forecast, by Design 14.21.1. Transcutaneous Ventricular Assist Devices 14.21.2. Implantable Ventricular Assist Devices 14.22. Japan Ventricular Assist Device Market Forecast, by Product 14.22.1. Left Ventricular Assist Device 14.22.2. Right Ventricular Assist Device 14.22.3. Bi-Ventricular Assist Device 14.23. Japan Ventricular Assist Device Market Forecast, by Flow 14.23.1. Pulsatile Flow 14.23.2. Continuous Flow 14.24. Japan Ventricular Assist Device Market Forecast, by Application 14.24.1. Bridge to Transplant 14.24.2. Destination Therapy 14.24.3. Bridge-to-recovery Therapy 14.24.4. Bridge-to-candidacy Therapy 14.24.5. Others 14.25. Japan Ventricular Assist Device Market Forecast, by Design 14.25.1. Transcutaneous Ventricular Assist Devices 14.25.2. Implantable Ventricular Assist Devices 14.26. ASEAN Ventricular Assist Device Market Forecast, by Product 14.26.1. Left Ventricular Assist Device 14.26.2. Right Ventricular Assist Device 14.26.3. Bi-Ventricular Assist Device 14.27. ASEAN Ventricular Assist Device Market Forecast, by Flow 14.27.1. Pulsatile Flow 14.27.2. Continuous Flow 14.28. ASEAN Ventricular Assist Device Market Forecast, by Application 14.28.1. Bridge to Transplant 14.28.2. Destination Therapy 14.28.3. Bridge-to-recovery Therapy 14.28.4. Bridge-to-candidacy Therapy 14.28.5. Others 14.29. ASEAN Ventricular Assist Device Market Forecast, by Design 14.29.1. Transcutaneous Ventricular Assist Devices 14.29.2. Implantable Ventricular Assist Devices 14.30. Rest of Asia Pacific Ventricular Assist Device Market Forecast, by Product 14.30.1. Left Ventricular Assist Device 14.30.2. Right Ventricular Assist Device 14.30.3. Bi-Ventricular Assist Device 14.31. Rest of Asia Pacific Ventricular Assist Device Market Forecast, by Flow 14.31.1. Pulsatile Flow 14.31.2. Continuous Flow 14.32. Rest of Asia Pacific Ventricular Assist Device Market Forecast, by Application 14.32.1. Bridge to Transplant 14.32.2. Destination Therapy 14.32.3. Bridge-to-recovery Therapy 14.32.4. Bridge-to-candidacy Therapy 14.32.5. Others 14.33. Rest of Asia Pacific Ventricular Assist Device Market Forecast, by Design 14.33.1. Transcutaneous Ventricular Assist Devices 14.33.2. Implantable Ventricular Assist Devices 14.34. Asia Pacific Ventricular Assist Device Market Attractiveness Analysis 14.34.1. By Product 14.34.2. By Flow 14.34.3. By Application 14.34.4. By Design 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Ventricular Assist Device Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Ventricular Assist Device Market Overview 15.3. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Product 15.4. Middle East & Africa Ventricular Assist Device Market Forecast, by Product 15.4.1. Left Ventricular Assist Device 15.4.2. Right Ventricular Assist Device 15.4.3. Bi-Ventricular Assist Device 15.5. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Flow 15.6. Middle East & Africa Ventricular Assist Device Market Forecast, by Flow 15.6.1. Pulsatile Flow 15.6.2. Continuous Flow 15.7. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Application 15.8. Middle East & Africa Ventricular Assist Device Market Forecast, by Application 15.8.1. Bridge to Transplant 15.8.2. Destination Therapy 15.8.3. Bridge-to-recovery Therapy 15.8.4. Bridge-to-candidacy Therapy 15.8.5. Others 15.9. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Design 15.10. Middle East & Africa Ventricular Assist Device Market Forecast, by Design 15.10.1. Transcutaneous Ventricular Assist Devices 15.10.2. Implantable Ventricular Assist Devices 15.11. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Country 15.12. Middle East & Africa Ventricular Assist Device Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Ventricular Assist Device Market Analysis, by Country 15.14. GCC Ventricular Assist Device Market Forecast, by Product 15.14.1. Left Ventricular Assist Device 15.14.2. Right Ventricular Assist Device 15.14.3. Bi-Ventricular Assist Device 15.15. GCC Ventricular Assist Device Market Forecast, by Flow 15.15.1. Pulsatile Flow 15.15.2. Continuous Flow 15.16. GCC Ventricular Assist Device Market Forecast, by Application 15.16.1. Bridge to Transplant 15.16.2. Destination Therapy 15.16.3. Bridge-to-recovery Therapy 15.16.4. Bridge-to-candidacy Therapy 15.16.5. Others 15.17. GCC Ventricular Assist Device Market Forecast, by Design 15.17.1. Transcutaneous Ventricular Assist Devices 15.17.2. Implantable Ventricular Assist Devices 15.18. South Africa Ventricular Assist Device Market Forecast, by Product 15.18.1. Left Ventricular Assist Device 15.18.2. Right Ventricular Assist Device 15.18.3. Bi-Ventricular Assist Device 15.19. South Africa Ventricular Assist Device Market Forecast, by Flow 15.19.1. Pulsatile Flow 15.19.2. Continuous Flow 15.20. South Africa Ventricular Assist Device Market Forecast, by Application 15.20.1. Bridge to Transplant 15.20.2. Destination Therapy 15.20.3. Bridge-to-recovery Therapy 15.20.4. Bridge-to-candidacy Therapy 15.20.5. Others 15.21. South Africa Ventricular Assist Device Market Forecast, by Design 15.21.1. Transcutaneous Ventricular Assist Devices 15.21.2. Implantable Ventricular Assist Devices 15.22. Rest of Middle East & Africa Ventricular Assist Device Market Forecast, by Product 15.22.1. Left Ventricular Assist Device 15.22.2. Right Ventricular Assist Device 15.22.3. Bi-Ventricular Assist Device 15.23. Rest of Middle East & Africa Ventricular Assist Device Market Forecast, by Flow 15.23.1. Pulsatile Flow 15.23.2. Continuous Flow 15.24. Rest of Middle East & Africa Ventricular Assist Device Market Forecast, by Application 15.24.1. Bridge to Transplant 15.24.2. Destination Therapy 15.24.3. Bridge-to-recovery Therapy 15.24.4. Bridge-to-candidacy Therapy 15.24.5. Others 15.25. Rest of Middle East & Africa Ventricular Assist Device Market Forecast, by Design 15.25.1. Transcutaneous Ventricular Assist Devices 15.25.2. Implantable Ventricular Assist Devices 15.26. Middle East & Africa Ventricular Assist Device Market Attractiveness Analysis 15.26.1. By Product 15.26.2. By Flow 15.26.3. By Application 15.26.4. By Design 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Ventricular Assist Device Market Analysis 16.1. Key Findings 16.2. South America Ventricular Assist Device Market Overview 16.3. South America Ventricular Assist Device Market Value Share Analysis, by Product 16.4. South America Ventricular Assist Device Market Forecast, by Product 16.4.1. Left Ventricular Assist Device 16.4.2. Right Ventricular Assist Device 16.4.3. Bi-Ventricular Assist Device 16.5. South America Ventricular Assist Device Market Value Share Analysis, by Flow 16.6. South America Ventricular Assist Device Market Forecast, by Flow 16.6.1. Pulsatile Flow 16.6.2. Continuous Flow 16.7. South America Ventricular Assist Device Market Value Share Analysis, by Application 16.8. South America Ventricular Assist Device Market Forecast, by Application 16.8.1. Bridge to Transplant 16.8.2. Destination Therapy 16.8.3. Bridge-to-recovery Therapy 16.8.4. Bridge-to-candidacy Therapy 16.8.5. Others 16.9. South America Ventricular Assist Device Market Value Share Analysis, by Design 16.10. South America Ventricular Assist Device Market Forecast, by Design 16.10.1. Transcutaneous Ventricular Assist Devices 16.10.2. Implantable Ventricular Assist Devices 16.11. South America Ventricular Assist Device Market Value Share Analysis, by Country 16.12. South America Ventricular Assist Device Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Ventricular Assist Device Market Analysis, by Country 16.14. Brazil Ventricular Assist Device Market Forecast, by Product 16.14.1. Left Ventricular Assist Device 16.14.2. Right Ventricular Assist Device 16.14.3. Bi-Ventricular Assist Device 16.15. Brazil Ventricular Assist Device Market Forecast, by Flow 16.15.1. Pulsatile Flow 16.15.2. Continuous Flow 16.16. Brazil Ventricular Assist Device Market Forecast, by Application 16.16.1. Bridge to Transplant 16.16.2. Destination Therapy 16.16.3. Bridge-to-recovery Therapy 16.16.4. Bridge-to-candidacy Therapy 16.16.5. Others 16.17. Brazil Ventricular Assist Device Market Forecast, by Design 16.17.1. Transcutaneous Ventricular Assist Devices 16.17.2. Implantable Ventricular Assist Devices 16.18. Mexico Ventricular Assist Device Market Forecast, by Product 16.18.1. Left Ventricular Assist Device 16.18.2. Right Ventricular Assist Device 16.18.3. Bi-Ventricular Assist Device 16.19. Mexico Ventricular Assist Device Market Forecast, by Flow 16.19.1. Pulsatile Flow 16.19.2. Continuous Flow 16.20. Mexico Ventricular Assist Device Market Forecast, by Application 16.20.1. Bridge to Transplant 16.20.2. Destination Therapy 16.20.3. Bridge-to-recovery Therapy 16.20.4. Bridge-to-candidacy Therapy 16.20.5. Others 16.21. Mexico Ventricular Assist Device Market Forecast, by Design 16.21.1. Transcutaneous Ventricular Assist Devices 16.21.2. Implantable Ventricular Assist Devices 16.22. Rest of South America Ventricular Assist Device Market Forecast, by Product 16.22.1. Left Ventricular Assist Device 16.22.2. Right Ventricular Assist Device 16.22.3. Bi-Ventricular Assist Device 16.23. Rest of South America Ventricular Assist Device Market Forecast, by Flow 16.23.1. Pulsatile Flow 16.23.2. Continuous Flow 16.24. Rest of South America Ventricular Assist Device Market Forecast, by Application 16.24.1. Bridge to Transplant 16.24.2. Destination Therapy 16.24.3. Bridge-to-recovery Therapy 16.24.4. Bridge-to-candidacy Therapy 16.24.5. Others 16.25. Rest of South America Ventricular Assist Device Market Forecast, by Design 16.25.1. Transcutaneous Ventricular Assist Devices 16.25.2. Implantable Ventricular Assist Devices 16.26. South America Ventricular Assist Device Market Attractiveness Analysis 16.26.1. By Product 16.26.2. By Flow 16.26.3. By Application 16.26.4. By Design 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. CardiacAssist, Inc. 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Manufacturing Footprint 17.3.1.7. Berlin Heart GmbH 17.3.1.8. Jarvik Heart, Inc. 17.3.1.9. ABIOMED, Inc. 17.3.1.10. Medtronic plc. 17.3.1.11. Abbott Laboratories 17.3.1.12. ReliantHeart Inc. 17.3.1.13. Teleflex Incorporated 17.3.1.14. Carmat SA 17.3.1.15. Sun Medical Technology Research Corp. 17.3.1.16. Bivacor 17.3.1.17. Calon Cardio-Technology Ltd. 17.3.1.18. LivaNova PLC 17.3.1.19. Terumo Medical Corporation. 17.3.1.20. Evaheart Medical USA, Inc. 17.3.1.21. Fresenius Medical Care AG & Co. KGaA 17.3.1.22. Maquet GmbH 17.3.1.23. HeartWare International, Inc. 18. Primary Key Insights

About This Report

Report ID 31262
Category Medical Devices
Published Date June 2022
Updated Date
Contact Us